Science Explorer Back to mapMap
Discussion
Researcher · Tohoku University · Japan

Erika Noro

Erika Noro publishes mostly in Molecular Biology, Endocrinology, Diabetes and Metabolism and Cellular and Molecular Neuroscience, on topics such as Glycosylation and Glycoproteins Research, Hormonal Regulation and Hypertension and Nuclear Receptors and Signaling.

OpenAlex
World rank
#5,096,411
of 7,710,434 ranked researchers
Rank in Japan
#162,625
of 383,136
Works
18
Citations
323
Citations per work
17.9
h-index
10
i10-index 10Top 76% in Molecular Biology
Erika Noro

What does Erika Noro research?

Erika Noro's work is mostly in Biochemistry, Genetics and Molecular Biology (31%), Medicine (18%), Neuroscience (8%).

Life Sciences: 8 works · 43.1% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 31.4% of their workMolecular Biology: 6 works · 31.4% of their workNeuroscience: 1 works · 7.8% of their workCellular and Molecular Neuroscience: 1 works · 7.8% of their workImmunology and Microbiology: 1 works · 3.9% of their workImmunology: 1 works · 3.9% of their workEverything else: 6 works · 31.4% of their workHealth Sciences: 3 works · 17.7% of their workMedicine: 3 works · 17.7% of their workEndocrinology, Diabetes and Metabolism: 2 works · 11.8% of their workRadiology, Nuclear Medicine and Imaging: 1 works · 5.9% of their workPhysical Sciences: 1 works · 7.8% of their workChemistry: 1 works · 7.8% of their workOrganic Chemistry: 1 works · 7.8% of their workTHEIR WORKErika Noro18works
Life Sciences43%Physical Sciences8%Health Sciences18%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology631.4%
    2. Neuroscience17.8%
    3. Immunology and Microbiology13.9%
  2. Everything else631.4%
    1. Medicine317.7%
    1. Chemistry17.8%
  1. 1Molecular Biology31% of their works
  2. 2Endocrinology, Diabetes and Metabolism12% of their works
  3. 3Cellular and Molecular Neuroscience8% of their works
  4. 4Organic Chemistry8% of their works
  5. 5Radiology, Nuclear Medicine and Imaging6% of their works
  6. 6Immunology4% of their works

Research topics

Which keywords describe Erika Noro's research?

The keywords of their largest research topics: Glycosylation, Cancer, Glycans, Nuclear Receptors, Transcriptional Regulation, Aldosterone, Primary Aldosteronism and Glycosidase Inhibitors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Glycosylation102 topics
  2. Cancer71 topic
  3. Glycans71 topic
  4. Nuclear Receptors62 topics
  5. Transcriptional Regulation62 topics
  6. Aldosterone51 topic
  7. Primary Aldosteronism51 topic
  8. Glycosidase Inhibitors41 topic
  9. NR4A241 topic
  10. Nurr141 topic
  11. Oligosaccharide Synthesis41 topic
  12. Fc Receptors31 topic
  13. Therapeutic Antibodies31 topic
  14. Cholesterol21 topic
  15. Estrogen21 topic
  16. Metabolism21 topic
  17. Receptor21 topic
  18. Biotechnological Applications11 topic
  19. Microbial Enzymes11 topic

Where does Erika Noro work?

Erika Noro's main affiliation in the publication record is Tohoku University, Japan.

How many publications and citations does Erika Noro have?

OpenAlex counts 18 works and 323 citations for Erika Noro, an h-index of 10, ranking #5,096,411 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Erika Noro. Posts are plain text and can be reported.